Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma

Leukemia Research

Volumn 36, Issue 10, 2012, Pages 1267-1273

  Ramirez, Elisa ^a   Singh, Rajesh R ^a   Kunkalla, Kranthi ^a   Liu, Yadong ^a   Qu, Changju ^a   Cain, Christine ^a   Multani, Asha S ^a   Lennon, Patrick A ^b   Jackacky, Jared ^a   Ho, Michael ^a   Dawud, Sity ^a   Gu, Jun ^a   Yang, Su ^a   Hu, Peter C ^a   Vega, Francisco ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PathGroup   (United States)

Author keywords

Diffuse large B cell lymphoma; Gene copy number; GLI; Hedgehog pathway

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ANEUPLOIDY; ARTICLE; CARCINOGENESIS; CHROMOSOME ANALYSIS; COPY NUMBER VARIATION; ENZYME INHIBITION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; GLI1 GENE; HEDGEHOG GENE; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; MOLECULAR INTERACTION; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMO GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; HEDGEHOG PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84865163381     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.06.014     Document Type: Article

References (32)

1. McMahon A.P., Ingham P.W., Tabin C.J. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 2003, 53:1-114.
2. Johnson R.L., Scott M.P. New players and puzzles in the Hedgehog signaling pathway. Curr Opin Genet Dev 1998, 8:450-456.
3. Murone M., Rosenthal A., de Sauvage F.J. Hedgehog signal transduction: from flies to vertebrates. Exp Cell Res 1999, 253:25-33.
4. Eichberger T., Sander V., Schnidar H., Regl G., Kasper M., Schmid C., et al. Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 2006, 87:616-632.
5. Guessous F., Li Y., Abounader R. Signaling pathways in medulloblastoma. J Cell Physiol 2008, 217:577-583.
6. Pasca di Magliano M., Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003, 3:903-911.
7. Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004, 431:707-712.
8. Singh R.R., Kim J.E., Davuluri Y., Drakos E., Cho-Vega J.H., Amin H.M., et al. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 2010, 24:1025-1036.
9. Singh R.R., Cho-Vega J.H., Davuluri Y., Ma S., Kasbidi F., Milito C., et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res 2009, 69:2550-2558.
10. Irvine D.A., Copland M. Targeting hedgehog in hematologic malignancy. Blood 2012, 119:2196-2204.
11. Hegde G.V., Munger C.M., Emanuel K., Joshi A.D., Greiner T.C., Weisenburger D.D., et al. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Mol Cancer Ther 2008, 7:1450-1460.
12. Greaves W.O., Kim J.E., Singh R.R., Drakos E., Kunkalla K., Sanchez-Espiridion B., et al. Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Hum Pathol 2011, 42:1643-1652.
13. Ok C.Y., Singh R.R., Vega F. Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. Am J Pathol 2012, 180:2-11.
14. Kim J.E., Singh R.R., Cho-Vega J.H., Drakos E., Davuluri Y., Khokhar F.A., et al. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol 2009, 22:1312-1320.
15. Vega F., Cho-Vega J.H., Lennon P.A., Luthra M.G., Bailey J., Breeden M., et al. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes. Br J Haematol 2008, 142:216-226.
16. Rao P.H., Houldsworth J., Dyomina K., Parsa N.Z., Cigudosa J.C., Louie D.C., et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998, 92:234-240.
17. Bea S., Colomo L., Lopez-Guillermo A., Salaverria I., Puig X., Pinyol M., et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol 2004, 22:3498-3506.
18. Sander S., Bullinger L., Leupolt E., Benner A., Kienle D., Katzenberger T., et al. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations. Haematologica 2008, 93:680-687.
19. Stecca B., Ruiz I.A.A. Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2010, 2:84-95.
20. Vega F., Medeiros L.J., Leventaki V., Atwell C., Cho-Vega J.H., Tian L., et al. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res 2006, 66:6589-6597.
21. Singh R.R., Kunkalla K., Qu C., Schlette E., Neelapu S.S., Samaniego F., et al. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 2011, 30:4874-4886.
22. Pasqualucci L., Trifonov V., Fabbri G., Ma J., Rossi D., Chiarenza A., et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011, 43:830-837.
23. Morin R.D., Mendez-Lago M., Mungall A.J., Goya R., Mungall K.L., Corbett R.D., et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011, 476:298-303.
24. Vestergaard J., Lind-Thomsen A., Pedersen M.W., Jarmer H.O., Bak M., Hasholt L., et al. GLI1 is involved in cell cycle regulation and proliferation of NT2 embryonal carcinoma stem cells. DNA Cell Biol 2008, 27:251-256.
25. Al-Kuraya K., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res 2004, 64:8534-8540.
26. Li S., Lin P., Fayad L.E., Lennon P.A., Miranda R.N., Yin C.C., et al. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 2012, 25:146-156.
27. Snuderl M., Kolman O.K., Chen Y.B., Hsu J.J., Ackerman A.M., Dal Cin P., et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 2010, 34:327-340.
28. Yang L., Wang Y., Mao H., Fleig S., Omenetti A., Brown K.D., et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol 2008, 48:98-106.
29. Rao G., Pedone C.A., Del Valle L., Reiss K., Holland E.C., Fults D.W. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004, 23:6156-6162.
30. Bushdid P.B., Brantley D.M., Yull F.E., Blaeuer G.L., Hoffman L.H., Niswander L., et al. Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature 1998, 392:615-618.
31. Nakashima H., Nakamura M., Yamaguchi H., Yamanaka N., Akiyoshi T., Koga K., et al. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res 2006, 66:7041-7049.
32. Kasperczyk H., Baumann B., Debatin K.M., Fulda S. Characterization of sonic hedgehog as a novel NF-kappaB target gene that promotes NF-kappaB-mediated apoptosis resistance and tumor growth in vivo. FASEB J 2009, 23:21-33.